Objective-To investigate the predictive value of fasting insulin concentrations for subsequent fatal or non-fatal ischaemic heart disease at five year follow up and to examine the associations between insulin and other indicators of risk. Design-A prospective population study among 2512 men aged 45 to 59 at recruitment. Setting-A whole population sample of men resident in Caerphilly, South Wales. Measurements-At recruitment fasting blood samples were taken for measurement of plasma lipids and serum insulin. Men were re-examined at a five year follow up and ischaemic heart disease events during this period were assessed from hospital notes, death certificates, and electrocardiograms. Main results-Diabetic men and those men with a fasting blood glucose of > 8 mmoMl were excluded from all analyses. In a univariate analysis the incidence of ischaemic heart disease increased with increasing concentration of fasting insulin, such that for men in the top 200/o of the insulin distribution the odds of developing ischaemic heart disease were 1l87 relative to men in the bottom 20%.
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On multivariate analysis this relation disappeared on adjusting for plasma triglycerides, body mass index, and evidence of ischaemic heart disease at recruitment. Conclusion Table 1 shows the incidence of ischaemic heart disease by fifths of the distribution of insulin and the age adjusted relative odds. The relative odds increased steadily with increasing insulin concentration, to a value of 1 87 in the top 20% of the insulin distribution. This trend is significant (p = 0 04).
Fasting serum insulin was positively associated with total cholesterol (r = 0 13), triglycerides (r = 0 48), diastolic (r = 0.17) and systolic (r = 013) blood pressure, body mass Insulin in ischaemic heart disease: are associations explained by triglyceride concentrations? The CaerphiUly prospective study The strongest associations were with triglycerides and body mass index. The associations with blood pressure seemed to arise largely because both insulin and blood pressure were associated with body mass index. The partial correlation coefficient between diastolic pressure and insulin on adjustment for body mass index was only 0 07. Similarly, the associations between total and high density lipoprotein cholesterol and insulin were secondary to the association of all three with triglycerides. Therefore in the multivariate analysis, triglycerides and body mass index, together with evidence of ischaemic heart disease at recruitment, were considered as the most likely confounding factors of the relation between insulin and incident ischaemic heart disease.
MULTIVARIATE ANALYSES
For insulin the age adjusted, standardised relative odds for ischaemic heart disease were 1-20 (p = 0-04) with a 95% CI from 101 to 1-44. Table 2 shows the effect of adjusting the standardised relative odds for ischaemic heart disease successively for triglycerides, body mass index, and pre-existing ischaemic heart disease with the multiple logistic regression. The addition of triglyceride removed almost half of the insulin effect and the further addition of pre-existing ischaemic heart disease removed about one half of the remaining effect. This was further reduced by the addition of body mass index.
This analysis was confirmed by a multiple regression (covariance) analysis with log [insulin] as the dependent variable, in which the mean difference in log [insulin] between men who developed ischaemic heart disease and those who did not was calculated. Table 4 shows the changes in the mean difference as successive confounding factors were added to the model. The results confirmed that successive adjustment for confounding variables, and for triglycerides in particular, almost eliminated the association between insulin concentrations and subsequent ischaemic heart disease.
Discussion
In a five year follow up of middle aged men, those who had developed ischaemic heart disease were found to have significantly higher concentrations of serum insulin measured at recruitment than those in men who had not developed ischaemic heart disease. This relation also showed incremental increases in risk of ischaemic heart disease when subjects were stratified by fifths of their recruitment concentration of insulin. In two multivariate analyses in which potentially confounding factors were taken into account the relation was found to be mainly explained by plasma triglyceride concentration, pre-existing ischaemic heart disease, and body mass index. Plasma triglyceride was found to be a strong and independent predictor for ischaemic heart disease in the Caerphilly and Speedwell study populations,19 although other prospective studies have not consistently identified triglyceride as a major risk factor.20
Two7 8 out of three9 prospective studies showed that insulin concentrations were univariately predictive of ischaemic heart disease and others have proposed mechanisms by which hyperinsulinaemia might be atherogenic21 and associated with hypertension.22 In multivariate analysis, fasting insulin concentration could not be shown to be an independent predictor for ischaemic heart disease in either the Helsinki7 or Paris8 studies. In the Helsinki study there was some suggestion of an independent role for insulin (p = 0-12) after adjustment for confounding factors including both triglycerides and body mass index. The Paris study did not include either triglycerides or body mass index among its confounding factors. In our study the effect of insulin almost entirely disappeared on adjusting for these two factors. None of these studies are large. The Helsinki7 study was based on 63 cases and the Paris8 study on 174 cases of incident ischaemic heart disease, and our study had 1 13 cases.
Several studies have noted a clustering of risk factors around insulin resistance3 4; these factors generally include hyperlipidaemia (usually triglyceride), hypertension, and obesity. Some Without exception all previous studies of the relation between circulating "insulin" and the incidence or prevalence of ischaemic heart disease including this one have used assays that measure total immunoreactive insulih rather than native insulin itself. In the present analysis, diabetic subjects and subjects with fasting glucose concentrations of > 80 mmol/l are excluded, and it is only in such subjects that proinsulin and its cleavage products may constitute a significant proportion of total immunoreactive insulin. Any bias introduced by inaccurate assessment of atherogenic proinsulin cleavage products is likely therefore to be small.
Some authors have suggested that fasting insulin concentrations are not a reliable index of insulin secretion.34 Thus the non-fasting state may be more relevant to the study of insulin and ischaemic heart disease but in epidemiological studies this is difficult to achieve in a standard, relevant manner. More experimental data on the response of insulin secretion to particular nutrients may be helpful.
In our study fasting plasma triglyceride was the major independent lipid marker of risk for the development of subsequent ischaemic heart disease.'9 Further research on the mechanism of the association between triglyceride and ischaemic heart disease is particularly required.
